The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.

A major Australian study finds standard antidepressants are not effective for around 20 per cent of people, who may need ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

The diabetic neuropathy market is poised for growth driven by clinical evidence, patient-centric care, digital health models, and innovative pharmacologic options. Key opportunities include enhancing ...

The emotion regulation system is commonly described as comprising of three interacting systems: threat, drive and soothing ...

Axsome Therapeutics AXSM announced the initiation of the phase III study called FORWARD with the dosing of the first patient, ...

Oprah Winfrey has offered a striking explanation for her long battle with weight, arguing that obesity is not caused by ...

Researchers from Denmark have uncovered strong evidence that depression often appears years before Parkinson’s disease and ...

Jia’s team developed a protocol to improve the screening of protein pockets. This involved identifying the pockets, removing ...

How the tobacco industry rebranded a brutally addictive drug from deadly to desirable—and what it means for our health.

Alcohol use is widespread and alcohol use disorder (AUD) causes substantial harm. AUD affects 29 million individuals and causes more than 140,000 deaths annually in the U.S. alone. Individuals with ...

This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: It’s common for sleep issues to increase during ...